ethyl 2-isothiocyanato-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate, 10g

BENZYL 3-HYDROXY-2-METHYLPROPYLCARBAMATE, 95.0%, 250mg

tert-Butyl 4-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate, 95.0%, 250mg

Chlorhexidine Dihydrochloride>96.0%(T)5g

(S)-methyl 3-(4-(2-acetyl-1-methyl-1H-imidazol-4-yl)phenyl)-2-((tert-butoxycarbonyl)amino)propanoate, 98%, 100mg

Mandatory signs tested in practice, 100 mm, 1 piece

(R)-Methyl 2-acetamidopropanoate, 95.0%, 5g

8-Methoxyquinoline-2-carboxylic acid, 95.0%, 250mg

Ulixertinib, 10mg

(4-(Benzyloxy)-3-chlorophenyl)boronic acid, 95.0%, 100g

Tetradecan-2-one, 95.0%, 100mg

tert-Butyl (R)-2-(tert-butyl)piperazine-1-carboxylate hydrochloride, 95%, 1g

N-(2-Hydroxyphenyl)methanesulfonamide, 95.0%, 5g